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Abstract
Background: Chronic Kidney Disease (CKD) is a complicated kidney problem causing permanent renal failure
in progressive stages. The final stage of CKD is called ESRD in which most accepted management is Hemodi-
alysis (HD). Arterio-Venus Fistula (AVF) is the most practical way of making proper access to the blood circu-
latory system; however, maturation of the AVF is a challenge, since there are number of variables interfering
with the whole process. The purpose of this study was to evaluate potentially modifiable factors associated with
Maturation Time (MT) after creation of a Vascular Access (VA).
Methods: In this cross-sectional study, a total of 87 patients referred to the Hasheminejad Kidney Center for
AVF creation in 2010 were evaluated. Patients were evaluated before and after the AVF creation and risk fac-
tors such as history of blood pressure abnormalities, diabetes and congestive heart failure, as well as the succes-
sive development of AVF was studied and finally processed using ‘data mining’ technology.
Results: The “Decision Trees” indicated the significant impact of the systolic blood pressure (SBP) in the delay
of the patient’s AVF maturation. Also, prediction of AVF maturation was made with 70.59% of precision in
regard to their BP condition.
Conclusion: This study demonstrated that monitoring the SBP is one of the important steps in management of
the cardiovascular variables producing any delay in the process of the patient’s HD. Also the data mining meth-
od can discover the hidden relationship between the patient’s medical conditions in order to predict the potential
disorders.
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Introduction
According to the Kidney Disease Quality
Outcome Initiative (K/DOQI), chronic kid-
ney disease (CKD) is defined as the atro-
phy of the kidney or failure of renal func-
tion (1). The progression of renal disease
can be separated into five stages, the crite-
rion of which is glomerular filtration rate
(GFR). Patients in the first stage share simi-
lar GFR (≥90) to healthy counterparts (kid-
ney damage with normal or increased
GFR), making it difficult to identify the
disease according to GFR alone. Stage 4, or
pre-End-Stage Renal Disease (ESRD), has
a GFR level of 15–29 mL/min/1.73 m2 (se-
verely decreased GFR). Finally, ESRD is
declared upon the fifth stage when the kid-
ney is completely deprived of its function.
If transplantation is not available, it is cru-
cial to undergo dialysis at this point (2).
Hemodialysis (HD) process requires a vas-
cular access (VA) which can be perform by
three common surgeries: ArterioVenous
Fistula (AVF), ArterioVenous graft (AVG)
or Central Venous Catheter (CVC) (3).
According to KDOQI HD Adequacy
guidelines, the preference of AVF over
other forms of access arises from their
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functional advantages because of a lower
rate of complications. Fistulae have the
lowest rate of thrombosis, and require the
fewest interventions, providing longer sur-
vival of the access (4). Catheters may cause
central vein stenosis, which can adversely
affect VA outcomes (5). Our criteria for
AVF maturation was: (i) easily palpable
superficial vein, (ii) vein relatively straight,
(iii) adequate diameter for easy cannulating
needles (3-4 mm), (iv) adequate length
(≥10 cm, for adequate distance between the
cannulating needles), and (v) uniform thrill
to palpation and auscultation. We evaluated
these criteria by nurses or nephrologists or
surgeon (6). AVGs require far more inter-
ventions than do AVFs to maintain long-
term patency for dialysis. On the average,
the annual frequency of intervention (elec-
tive angioplasty, thrombectomy, or surgical
revision) in mature accesses is approxi-
mately four-fold higher for AVGs than for
AVFs (7). Also the durability of AVF is
about 90% for a year after maturation for
the reason of dialysis, while this rate is only
60% for AVG (8).
Clinical guidelines established by the Na-
tional Kidney Foundation cite these reasons
in advocating use of AVFs whenever pos-
sible (9). Placement rates for each type of
access have changed dramatically over the
last 10 years (10), with a decrease in cathe-
ter placement rates and an increase in AVF
placement rates (11). In 2003, the using
rates of AVF has been reported in about
91% in Japan, and between 70% and 90%
in most European countries, compared with
a dismal 30% in the United States (Fig. 1)
(12).
Data from the DOPPS. Note the dismal
prevalence rate for native AVF and the
high prevalence rate for PTFE grafts in the
United States as compared with other in-
dustrialized countries. ANZ, Australia and
New Zealand; BE, Belgium; CA, Canada;
FR, France; GE, Germany; IT, Italy; Jpn,
Japan; SP, Spain; SW, Sweden; US, United
States (Data as of September, 2003; courte-
sy Dr. Rajiv Saran, University of Michigan,
Ann Arbor, MI.) (12).
The AVF using rate has reported to be
93.4% in Iran (13). In the USA, AVF use
increased from 27.9% in 1998 to 55.0% in
2007 (14) and shows an increase from
32.4% in 2003 to 57.9% in 2011 (15) and
has grown up into 61% in 2013 (16). Final-
ly, according the report Fiscal Year (FY)
2014 (16), increasing the rate of AVF ac-
cess for ESRD patients improves the quali-
ty of HD treatment, while decreasing un-
necessary complications and hospitaliza-
tions. Since FY 2009, CMS has increased
AVF access by over 6 percent, exceeding
recent targets (Table 1).
The AVF is the preferred type of vascular
access because thrombosis rates, infection
rates, access-related expenditures, and total
health care expenditures all are lower for
patients with fistulas than for those with
either synthetic AVG or CVC; However,
the advantages of fistulas are counterbal-
anced by the substantially higher propor-
tion of fistulas than grafts that are never
able to be used for dialysis because of fail-
ure to mature adequately to support effec-
tive HD (17). A much higher likelihood of
fistula non-maturation, ranging between
20% and 60% (18) and recent studies have
reported 20-50% of the fistulas failed to
maturation (19). There are several variables
interfering with the time takes for an AVF
to develop to become accessible for HD,
which all together can be divided into four
groups (20): first, demographic factors,
such as; age, race, economic condition and
geographic region (21), second, diagnostic
exams and evaluations before surgery, such
as, ultrasound results to examine the Arte-
rioVenus system and regional vascular
anatomy (22), third, measuring the physio-
logical variables during surgery, such as
fistula blood flow and dimensions of arter-
ies and veins (23), and the last group is re-
habilitative exercises and post operation
cares (24).
The NKF-KDOQI guidelines provides an
evidence based on clinical measurements
that a reciprocal relationship exists between
the blood pressure (BP) and CKD, in
which, BP is a cause and a consequence for
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CKD. Likewise, it has suggested the deter-
mination of the relation between the levels
of BP against time in ESRD patients (25).
Therefore, having information about the
factors which have impact on the matura-
tion time (MT) after AVF creation, can
help in screening and choosing the right
patients for the procedure and thus offering
better diagnostic services and treatments
and finally expediting the healing and mat-
uration period after AVF creation as well as
minimizing the side effects and eventually
preparing the patient for HD (26, 27). For
this reason, this study is prepared to inves-
tigate the impact of BP conditions on the
period in which takes the AVF to develop
for HD in ESRD patients. Also, studies the
interference of other variables such as age,
diabetes and cardiac failures with the pro-
cess.
Data mining is a process in extraction of
interesting (non-trivial, implicit, previously
unknown and potentially useful) patterns or
knowledge from huge amount of data. (28)
The outcome of Data Mining technologies
are to provide benefits to healthcare organi-
zation for grouping the patients having sim-
ilar type of diseases or health issues so that
healthcare organization provides them ef-
fective treatments; This analysis of health
data improves the healthcare by enhancing
the performance of patient management
tasks. (29) These approaches have develop-
ing implication in the health area and have
aided the clinical data description pro-
cessing via transaction of health systems
(30).
Methods
In this cross-sectional and prospective
study, the medical history of 87 patients
who referred to the Hasheminejad Kidney
Center for AVF creation in 2010 were ana-
lyzed. For all of the patients, the surgery
was performed within the radio-cephalic
area by one surgeon. Patients’ participation
was under total awareness and consent. The
patient’s information were recorded includ-
ing personal descriptions such as age and
gender, medical history before AVF crea-
tion, monitoring during operation (the op-
eration region) and potential risk factors
such as BP, diabetes and cardiac failures.
MT was considered as the time between the
AVF creation and accessibility. The AVF
accessibility was indicated by the length of
the straight superficial vein (should be
Fig. 1.Data from the DOPPS. Note the dismal prevalence rate for native AVF and the high prevalence rate for PTFE grafts
in the United States as compared with other industrialized countries. ANZ, Australia and New Zealand; BE, Belgium; CA,
Canada; FR, France; GE, Germany; IT, Italy; Jpn, Japan; SP, Spain; SW, Sweden; US, United States (Data as of Septem-
ber, 2003; courtesy Dr. Rajiv Saran, University of Michigan, Ann Arbor, MI.) (12).
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about 10cm), palpable with proper diameter
(about 4mm) and having continues and uni-
form thrill and continues bruit in ausculta-
tion (20). In this way, the fistulas matura-
tion times were recorded for a successful
HD and then the data were processed with
the data mining method. The maturation of
a fistula (becoming accessible for dialysis)
is described as a fistula condition which
can be cannulated with two needle probes
permanently or by routine and supply the
adequate blood flow (min 350-450 ml/min)
for a successful HD session (3-4 hours)
each time (31).
One of the data mining approaches is “de-
scriptive method”, which a subdivision of
that called clustering, was used in our pre-
vious study to explore the early failure of
the inserted AVF in 99 patients (32). An-
other approach is “predictive method”
which we have implemented in our recent
researches on 193 HD patients (33, 34).
In this study we use the “predictive ap-
proaches” in processing stage. The data
mining was performed by “Rapid Miner”,
before starting the data processing. For this
reason, the data were randomly sampled by
“Bootstrapping” algorism (70 samples).
Later, the “Decision Trees” (DT) were ex-
tracted, representing the impacts of differ-
ent variables on AVF maturation. There
were quite a few trees which were extracted
by this method, however, only those were
chosen for our two groups of data, which
according to the ‘compatibility rules of the
trees’ had better consistency with the Med-
ical Instruction Criteria (8, 22).
To improve processing, instead of enter-
ing all the data into the software, we have
defined these groups for age and maturation
time (MT). This definition is regarding the
average age of the patients and their MT
range. Before the processing, we had ‘data
preparation’ and categorize the data into
Table 1. Increase percentage of dialysis patients with AVF as their vascular access for HD. (11)
FY 2009 FY 2010 FY 2011 FY 2012 FY 2013 FY 2014
Target 54% 57% 58% 60.5% 61% 61%





Target Exceeded Pending Pending Pending
1Reporting on this target is delayed until November 2013.
Fig. 2.Infographic of our research-flow
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two frames: considering the average age of
the patients which is 57 years, we had two
subgroups: “below-57” and “above 57”.
Another group-related subgroups are: 19-
49, 50-64 and 65-83 years, labeled accord-
ingly. The MT has also been classified as
follow: class A: 3-4 weeks, class B: 5-7
weeks and class C: 8-10 weeks. There was
only one case of 16 weeks MT, which we
considered it as class C (Fig. 2).
Results
The medical characteristics of 87 patients
(including 61 (70%) male and 26 (30%)
female) diagnosed with CKD, was studied.
The mean (±SD) age of patients in this
study was 57.0 (± 16.36) years. The tree
related to the first group is illustrated in
Figure 3. This tree is a continuous type of
DT known as Classification and Regression
Trees (CART). (35) For clarificationof
findings (A, B and C)  in figures 3 and 4,
see previous paragraph; the words “Systol-
ic” and “Diastolic” are literally the systolic
blood pressure (SBP) and diastolic blood
pressure (DBP), accordingly. Also the la-
bels A, B and C are shown in blue, red and
green colors.
Table 2 displays the compatible laws with
this tree, which indicates that the patient’s
gender does not have any impact on the MT
of AVFs. On the other side, the systolic
blood pressure (SBP) is differentially an
important factor (Table 2).
While, the extracted knowledge from the
second group tree indicates that the SBP
and DBP have significant impact on the
MT. For the systolic BPs above 105-
122.5mmHg, the maturation accomplished
better in groups one and three than patients
with ages 50-64 years. Those groups’ matu-
Table 2.  Extracted rules from decision in Figure 3
If Systolic <= 105  Then "class C" {A=0, C=7, B=0}
If Systolic > 105 Then
If IHD = no  then "class A" {A=27, C=7, B=5}
If IHD = yes then
If  Diastolic <= 75  then "class A" {A=4, C=0, B=0}
If  Diastolic > 75 then
If   DM = no  then "class C" {A=0, C=2, B=1}
If   DM = yes then "class B" {A=2, C=0, B=15}
Table 3.  Extracted rules from decision in Figure 4
If  Systolic <= 105  Then "class C" {A=0, C=7, B=0} else
If  Systolic > 105
If  IHD = no then
If  Systolic <= 122.500  then
If  AGE = [19-49] then "class A" {A=2, C=0, B=0} else
If  AGE = [50-64] then "class C" {A=0, C=2, B=0} else
If  AGE = [65-83] then "class A" {A=4, C=3, B=0}
If  Systolic > 122.500 then "class A" {A=21, C=2, B=5}
If  IHD = yes then
If  Diastolic <= 75 then "class A" {A=4, C=0, B=0} else
If  Diastolic > 75 then
If DM = no then "class C" {A=0, C=2, B=1} else
If DM = yes then "class B" {A=2, C=0, B=15}
Table 4.  The accuracy rate of MT prediction
Accuracy rate: 70.59% true A true C true B Class precision
pred. A 6 2 1 66.67%
pred. C 0 4 2 66.67%
pred. B 0 0 2 100.00%
class recall 100.00% 66.67% 40.00%
Blood pressure effect on non-matured AVF
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ration times were classified in the class A
(Fig. 4, Table 3).
So far, few patients were randomly se-
lected and the system trained the rules ex-
tracted from their attributes. At the next
step of the data mining process, the quality
of the MT was predicted on the remaining
patients who were not selected in sampling
stage. We have 17 patients who were not
sampled in the training phase. The preci-
sion of this prediction was measured by the
“Performance algorithm”. The related pre-
Fig. 3.The decision tree diagram displaying the data mining for 70 patients using the first method
Fig. 4. The Decision tree on 70 patients classified on the basis of age into three subset of 19 to 49 years (with labels [19-
49]), 50 to 64 years (with labels [50-64]) and 65 to 83 years (with labels [65-83])
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cision was 70.59% (Table 4).
Discussion
One study have evaluated potentially
modifiable factors associated with dialysis
access patency using statistical methods
(36) and they have indicated the role of
maturation period blood pressure as a risk
factor.
In this study we evaluated medical char-
acteristics of the patients diagnosed with
CKD. We divided patients information into
two main groups based on their ages and
the data mining was performed on both
groups, followed by checking the compati-
bility of the study with the standard medi-
cal guidelines. Outcome of this process was
two ‘decision trees’. This method of study
indicated that the gender has not any spe-
cific impact on the time needed for the fis-
tula to mature and on the other hand, clear-
ly displayed the significant impact of the
patient’s systolic (SBP) and diastolic
(DBP) blood pressure on the AVF MT.
Moreover, the effects of other factors –
such as Ischemic Heart Disease (IHD) and
Diabetes Mellitus (DM) has been analyzed
in formulas (1):
SBP > IHD > DBP > DM > Age (1)
In addition to the descriptive results, the
AVF MT was evaluated with the 70.59% of
precision in 17 patients whose data were
not sampled in this investigation. Regard-
ing the high impact of the SBP and DBP in
the AVF MT, it is very important to con-
stantly monitor this variable in the CKD
patients before and during the AVF crea-
tion procedure and likewise, considering
this variable in the patient’s medical plans
for a successful HD.
Conclusion
Association of the blood pressure with the
fistula maturation time, may play an im-
portant role in vascular access patency. The
results of this study are not only important
in improving the physicians and surgeon’s
knowledge of the time of the accessibility
of the inserted fistulas, also, improves the
medical care provided to the patients.
This study also demonstrated that with
the use of the data mining it is not only
possible to uncover the unknown relations
between the medical characteristics related
to the disease with the patient’s general
condition, but also to predict the medical
conditions related to the disease in future
patients. Thus, the knowledge extracted
from the data mining method is considera-
bly helpful in making medical decisions
and predicting the patient’s condition relat-
ed to his treatment in similar situations.
Limitations of this study were limited
number of patients and lack of evaluation
of other factors which may have effects on
maturation process.
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